Carl Dolman

429 total citations
8 papers, 305 citations indexed

About

Carl Dolman is a scholar working on Genetics, Oncology and Immunology. According to data from OpenAlex, Carl Dolman has authored 8 papers receiving a total of 305 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Oncology and 3 papers in Immunology. Recurrent topics in Carl Dolman's work include Blood disorders and treatments (3 papers), Neutropenia and Cancer Infections (2 papers) and Platelet Disorders and Treatments (2 papers). Carl Dolman is often cited by papers focused on Blood disorders and treatments (3 papers), Neutropenia and Cancer Infections (2 papers) and Platelet Disorders and Treatments (2 papers). Carl Dolman collaborates with scholars based in United Kingdom, Netherlands and Italy. Carl Dolman's co-authors include Robin Thorpe, Susan J. Thorpe, B. Fox, Meenu Wadhwa, Chris Bird, Paula Dilger, G. M. TARRANT, Stephen Poole, Yogesh Mistry and Tony Meager and has published in prestigious journals such as The Journal of Immunology, Annals of the Rheumatic Diseases and Human Gene Therapy.

In The Last Decade

Carl Dolman

8 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Carl Dolman United Kingdom	7	200	113	78	77	32	8	305
Lucy Findlay United Kingdom	8	422 2.1×	226 2.0×	199 2.6×	139 1.8×	26 0.8×	9	595
Werner Frings United States	5	114 0.6×	86 0.8×	70 0.9×	49 0.6×	6 0.2×	10	211
Chia‐Huey Lin Germany	6	331 1.7×	29 0.3×	76 1.0×	37 0.5×	17 0.5×	7	389
Peter Brams United States	9	139 0.7×	110 1.0×	57 0.7×	163 2.1×	8 0.3×	19	355
Gennady V. Gololobov Russia	6	199 1.0×	390 3.5×	28 0.4×	303 3.9×	38 1.2×	8	524
B. Lisowska-Bernstein United States	10	259 1.3×	169 1.5×	39 0.5×	211 2.7×	23 0.7×	16	470
Nicole Piche‐Nicholas United States	9	104 0.5×	248 2.2×	72 0.9×	212 2.8×	20 0.6×	9	378
R. L. Ikonopisov United Kingdom	4	298 1.5×	88 0.8×	192 2.5×	93 1.2×	10 0.3×	7	411
Neha Deshpande United States	9	166 0.8×	27 0.2×	86 1.1×	60 0.8×	6 0.2×	21	309
Chae Reed United States	6	155 0.8×	276 2.4×	87 1.1×	255 3.3×	11 0.3×	7	402

Countries citing papers authored by Carl Dolman

Since Specialization

Citations

This map shows the geographic impact of Carl Dolman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carl Dolman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carl Dolman more than expected).

Fields of papers citing papers by Carl Dolman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carl Dolman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carl Dolman. The network helps show where Carl Dolman may publish in the future.

Co-authorship network of co-authors of Carl Dolman

This figure shows the co-authorship network connecting the top 25 collaborators of Carl Dolman. A scholar is included among the top collaborators of Carl Dolman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carl Dolman. Carl Dolman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Fox, B., Jason Hockley, Peter Rigsby, et al.. (2019). A WHO Reference Reagent for lupus (anti-dsDNA) antibodies: international collaborative study to evaluate a candidate preparation. Annals of the Rheumatic Diseases. 78(12). 1677–1680. 13 indexed citations

Meager, Anthony, Carl Dolman, Paula Dilger, et al.. (2010). An Assessment of Biological Potency and Molecular Characteristics of Different Innovator and Noninnovator Interferon-Beta Products. Journal of Interferon & Cytokine Research. 31(4). 383–392. 24 indexed citations

Zhao, Yuan, et al.. (2008). Characterization of Complete Particles (VSV-G/SIN-GFP) and Empty Particles (VSV-G/EMPTY) in Human Immunodeficiency Virus Type 1-Based Lentiviral Products for Gene Therapy: Potential Applications for Improvement of Product Quality and Safety. Human Gene Therapy. 19(5). 475–486. 7 indexed citations

Stebbings, Richard, Lucy Findlay, David Eastwood, et al.. (2007). “Cytokine Storm” in the Phase I Trial of Monoclonal Antibody TGN1412: Better Understanding the Causes to Improve PreClinical Testing of Immunotherapeutics. The Journal of Immunology. 179(5). 3325–3331. 222 indexed citations

Thorpe, Susan J., B. Fox, Carl Dolman, & Robin Thorpe. (2005). Anti-A and anti-B activity in batches of different intravenous immunoglobulin products determined using a direct haemagglutination method. Biologicals. 33(2). 111–116. 18 indexed citations

Codevilla, Cristiane Franco, et al.. (2004). Validation of an SEC‐HPLC Method for the Analysis of rhG‐CSF in Pharmaceutical Formulations. Journal of Liquid Chromatography & Related Technologies. 27(17). 2689–2698. 14 indexed citations

Dolman, Carl, Susan J. Thorpe, & Robin Thorpe. (2001). Enhanced Efficacy of Anti-D Immunoglobulin for Treating ITP is not Explained by Higher Immunoglobulin Polymer Content. Biologicals. 29(2). 75–79. 6 indexed citations

Mire‐Sluis, Anthony R., et al.. (1999). The Effects of Environmental Influences and Post‐translational Modification on the Biological Activity of Granulocyte Colony‐stimulating Factor. Pharmacy and Pharmacology Communications. 5(1). 45–49. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact